Loading interface...

Nasopat 0.6 % Nasal Spray

Manufactured byAjanta Pharma Ltd.
ContainsOlopatadine
Description
Nasopat 0.6 % Nasal Spray is an antihistamine used to relieve the symptoms of seasonal allergic rhinitis (hay fever) such as a stuffy, runny, or itchy nose, sneezing, etc. in adults and children aged 6 years and above.

Side effects

Major & minor side effects for Nasopat 0.6 % Nasal Spray

  • Perforation of nasal septum
  • Bleeding from nose
  • Sores inside the nose
  • Fatigue
  • Bitter taste

Uses of Nasopat 0.6 % Nasal Spray

What is it prescribed for?

  • Seasonal allergic rhinitis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 30 minutes of administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol together with this medicine increases the risk of drowsiness, dizziness, and difficulty in concentrating. It is advised that you do not consume alcohol or limit its use when being treated with this medicine. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if alcohol and this medicine are used together.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to olopatadine or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings

Use in children

This medicine is not recommended for use in patients less than 6 years of age since the safety and efficacy of use are not clinically established. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, the patient should be monitored closely for any undesirable side effects.

Driving or operating machinery

This medicine may rarely cause symptoms such as drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating heavy machinery if you experience any of these symptoms.

Local nasal effects

This medicine may cause adverse effects such as nasal ulceration, perforation of the nasal septum, bleeding from the nose, etc. in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition

Missed Dose

Use the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol together with this medicine increases the risk of drowsiness, dizziness, and difficulty in concentrating. It is advised that you do not consume alcohol or limit its use when being treated with this medicine. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if alcohol and this medicine are used together.
Interaction with Medicine

Amitriptyline

Disulfiram

Alprazolam

Sodium oxybate

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Follow all the instructions given by your doctor and administer this medicine exactly as advised. Do not administer in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by blocking histamine, a substance in the body that causes allergic symptoms.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Antihistamines, Nasal Decongestant

Schedule

Schedule H

Olopatadine - DrugBank [Internet]. Drugbank.ca. 2020 [cited 18 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB00768

Olopatadine [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 18 May 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Olopatadine

DailyMed - Patanase - olopatadine hydrochloride spray, metered [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 18 May 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24fb7339-f5a9-4d02-a492-43617729412b

Olopatadine Nasal Spray: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 18 May 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a615038.html

[Internet]. Accessdata.fda.gov. 2020 [cited 18 May 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021861s002lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.